Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
MAXALT MAX 10 MG LIOFILIZADO ORAL
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- RIZATRIPTAN BENZOATO — 10 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- 1 of 2 packs marketed
Packs
MAXALT MAX 10 MG LIOFILIZADO ORAL, 2 liofilizados
2 pcs
National code
Not marketed723985Strength of this pack 10 mg
MAXALT MAX 10 MG LIOFILIZADO ORAL, 6 liofilizados
6 pcs
National code
Marketed723986Strength of this pack 10 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
Registration
- Registration number
- 3400934794407Official data
- Marketing authorisation holder
- ORGANON FRANCEOfficial data
- Authorised
- Nov 8, 2018Official data
- Authority form code
- 45Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.